Sugammadex in rocuronium anaphylaxis: Dose matters

British Journal of Anaesthesia

Volumn 109, Issue 4, 2012, Pages 646-647

  Barthel, F ^a   Stojeba, N ^a   Lyons, G ^a   Biermann, C ^a   Diemunsch, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; METHYLPREDNISOLONE; PROPOFOL; ROCURONIUM; SUFENTANIL; SUGAMMADEX;

ADULT; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; BLOOD ANALYSIS; CASE REPORT; CRYSTALLOID; DRUG INFUSION; FEMALE; HUMAN; HYPOTENSION; LETTER; MORBID OBESITY; OXYGEN THERAPY; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

EID: 84866392400     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes332     Document Type: Letter

References (4)

1. Scadding GK. Remove the patient from contact with the allergen. Br Med J 1995; 311: 1434
2. Recommandations formalisées d'experts. Prévention du risque allergique peranesthésique. Texte court. Société française d'anésthesie et reanimation (Sfar), Socié téfrançaise d'allergologie (SFA)
3. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104: 919-42
4. McDonnell NJ, Pavy TJG, Green LK. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011; 106: 199-201